Saadia, R., and J. Lipman. “Antibiotics and the Gut.” European Journal of Surgery supp. 576 (1996): 39–41.
Zajicek, G., M.D. “Antibiotic Resistance and the Intestinal Flora.” Cancer Journal 9, no. 5 (September/October 1996): 214.
Zittell, N. K. “Is Antibiotic Use Coming Back to Haunt Us?” Medical Tribune, October 24, 1996, 18.
Chapter 15
Drugs for Insomnia, Anxiety, and Depression and Their Natural Alternatives
Adams, P. B., et al. “Arachidonic Acid to Eicosapentaenoic Acid Ratio in Blood Correlates Positively with Clinical Symptoms of Depression.” Lipids 31, supp. (1996): S-157–S-161.
AHRQ Publications, “S-Adenosyl-L-Methio-nine for Treatment of Depression, Osteoarthritis, and Liver Disease: Summary.” AHRQ Publication no. 02-E033 (August 2002), http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.88067.
Aldhous, P. “Antidepressants May Harm Male Fertility.” New Scientist (September 24, 2008).
Assisi A. et al. “Fish Oil and Mental Health: The Role of Omega-3 Long-Chain Poly-unsaturated Fatty Acids in Cognitive Development and Neurological Disorders.” International Clinical Psychopharmacology 21, no. 6 (November 2006); 319–36.
Borok, G., et al. “Atopy: The Incidence in Chronic Recurrent Maladies.” XVI European Congress of Allergology and Clinical Immunology, June 24–25, 1995.
Cincipirini, P. M., Ph.D. “Depression and Cholesterol-Lowering Chemotherapy: Potential Influence of Smoking Cessation, Depression History, and Dietary Change.” Behavioral Medicine (1996): 85–86.
Clouatre D. L. “Kava-kava: Examining New Reports of Toxicity.” Toxicology Letters 150, no. 1 (April 15, 2004): 85–96.
Corkeron, M. A. “Serotonin Syndrome—a Potentially Fatal Complication of Antidepressant Therapy.” Medical Journal of Australia 163 (November 6, 1995): 481–82.
Driver, H. S., and S. R. Taylor. “Sleep Disturbances and Exercise.” Sports Medicine 21, no. 1 (January 1996): 1–6.
Glenmullen, J., M.D. Prozac Backlash. New York: Simon & Schuster, 2000.
Helin-Salmivaara, A., T. Huttunen, J. M. Grönroos, et al. “Risk of Serious Upper Gastrointestinal Events with Concurrent Use of NSAIDs and SSRIs: A Case-Control Study in the General Population.” European Journal of Clinical Pharmacology 63, no. 4 (April 2007): 403–8.
Herber, K. W. “The Influence of Kava-Special Extract WS 1490 on Safety-Relevant Performance Alone and in Combination with Ethylalcohol.” Blutalkohol 30 (1993): 96–105.
King, A. C., Ph.D., et al. “Moderate-Intensity Exercise and Self-Rated Quality of Sleep in Older Adults: A Randomized Controlled Trial.” Journal of the American Medical Association 277, no. 1 (January 1, 1997): 32–37.
Kinzler, E., J. Kromer, and E. Lehmann. “Clinical Efficacy of a Kava Extract in Patients with Anxiety Syndrome: Double-Blind Placebo Controlled Study over 4 Weeks.” Arzneim Forsch 41 (1991): 584–88.
Lacasse, Jeffrey R., and Jonathan Leo, “Serotonin and Depression: A Disconnect Between the Advertisements and the Scientific Literature.” PLOS Medicine 2, no. 12 (December 5, 2005). http://medicine.plosjournals.org/archive/1549-1676/2/12/pdf/10.1371_journal.pmed.0020392-L.pdf.
Lawson, Willow. “Omega-3s for Boosting Mood.” Psychology Today, http://www.psychologytoday.com/articles/pto-20030103000005.html.
Lebot, V., M. Merlin, and L. Lindstrom. Kava—The Pacific Drug. New Haven, CT: Yale University Press, 1992.
Lietha, R., M.D. “Neuropsychiatric Disorders Associated with Folate Deficiency in the Presence of Elevated Serum and Erythrocyte Folate: A Preliminary Report.” Journal of Nutritional Medicine 4 (1994): 441–47.
Loke, Y. K., A. N. Trivedi, and S. Singh. “Meta-analysis: Gastrointestinal Bleeding Due to Interaction Between Selective Serotonin Uptake Inhibitors and Non-steroidal Anti-inflammatory Drugs.” Alimentary Pharmacology and Therapeutics 27, no. 1 (January 1, 2008): 31–40.
Maes, M., et al. “Lower Serum L-Tryptophan Availability in Depression as a Marker of a More Generalized Disorder in Protein Metabolism.” Neuropsychopharmacology 15, no. 3 (1996): 243–51.
_____. “Fatty Acid Composition in Major Depression: Decreased Omega-3 Fractions in Cholesterol Esters and Increased C20:406/C20:503 Ratio in Cholesterol Esters and Phospholipids.” Journal of Affective Disorders 38 (1996): 35–46.
Martinez, B., et al. “Hypericum in the Treatment of Seasonal Affective Disorders.” Journal of Geriatric Psychiatry and Neurology 7, supp. 1 (1994): S29–S33.
Meyer, T., and A. Brooks. “Therapeutic Impact of Exercise on Psychiatric Diseases: Guidelines for Exercise Testing and Prescription.” Sports Medicine 30, no. 4 (October 2000): 269–79.
Munte, T. F., et al. “Effects of Oxazepam and an Extract of Kava Roots on Event-Related Potentials in a Word Recognition Task.” Neuropsychobiology 27 (1993): 46–53.
Neumeister, A., M.D., et al. “Effects of Tryptophan Depletion on Drug-Free Patients with Seasonal Affective Disorder During a Stable Response to Bright Light Therapy.” Archives of General Psychiatry 54 (1997): 133–38.
Pilar, S., M.D. “Amelioration of Premenstrual Depressive Symptomatology with L-Tryptophan.” Journal of Psychiatry and Neuroscience 19, no. 2 (1994): 114–19.
Ploeckinger, B., et al. “Rapid Decrease of Serum Cholesterol Concentration and Post-partum Depression.” British Medical Journal 313 (September 14, 1996): 664.
Poulos, C. X., and M. Zack. “Low-Dose Diazepam Primes Motivation for Alcohol and Alcohol-Related Semantic Networks in Problem Drinkers.” Behavioral Pharmacology 15, no. 7 (November 2004): 503–12.
Reichert, R. G., N.D. “St. John’s Wort Extract as a Tricyclic Medication Substitute for Mild to Moderate Depression.” Quarterly Review of Natural Medicine (winter 1995): 275–78.
Reid, K., et al. “Day-Time Melatonin Administration: Effects on Core Temperature and Sleep Onset Latency.” Journal of Sleep Research 5 (1996): 150–54.
Scholing, W. E., and H. D. Clausen. “On the Effect of D, L-Kavain: Experience with Neuronika.” Medizinische Klinik 72 (1977): 1301–6.
Singh, Y. N. “Kava: An Overview.” Journal of Ethnopharmacology 37 (1992): 13–45.
_____. “Potential for Interaction of Kava and St. John’s Wort with Drugs.” Journal of Ethnopharmacology 100, nos. 1–2 (August 22, 2005): 108–13.
Stagnitti, M. “Antidepressant Use in the U.S. Civilian Non-institutionalized Population, 2002.” Statistical brief #77. Rockville, MD: Medical Expenditure Panel, Agency for Healthcare Research and Quality.
Szabadi, E. “St. John’s Wort and Its Active Principles in Depression and Anxiety.” British Journal of Clinical Pharmacology 62, no. 3 (September 2006): 377–78.
Thachil, A. F., R. Mohan, and D. Bhugra. “The Evidence Base of Complementary and Alternative Therapies in Depression.” Journal of Affective Disorders 97, no. 1–3 (January 2007): 23–35.
Volz, H. P., and M. Kieser. “Kava-Kava Extract WS 1490 Versus Placebo in Anxiety Disorders—a Randomized Placebo-Controlled 25-Week Outpatient Trial.” Pharmacopsychiatry 30 (1997): 1–5.
White, H. L., et al. “Extracts of Ginkgo Biloba Leaves Inhibit Monoamine Oxidase.” Life Sciences 58, no. 16 (1996): 1315–21.
Wiley, T. S., with Bent Formby, Ph.D. Lights Out: Sleep, Sugar, and Survival. New York, NY: Simon & Schuster, 2000.
“Working off depression.” Harvard Mental Health Letter 22, no. 6 (December 2005): 6–7.
Wright, K. P., Jr., et al. “Caffeine and Light Effects on Nighttime Melatonin and Temperature Levels in Sleep-Deprived Humans.” Brain Research 747 (1997): 78–84.
Zal, H. M. “Seasonal Affective Disorder: How to Lighten the Burden of Winter Depression.” Consultant (March 1997): 641–49.
Chapter 16
Diabetes Drugs, Obesity Drugs, and Their Natural Alternatives
Arivazhagan, P., K. Ramanathan, and C. Panneerselvam. “Effect of DL-Alpha-Lipoic Acid on Mitochondrial Enzymes in Aged Rats.” Chemical and Biological Interactions 138, no. 2 (November 28, 2001): 189–98.
&nbs
p; Aron, D. C., and T. Hornick. “Managing Diabetes in the Elderly: Go Easy, Individualize.” Cleveland Clinic Journal of Medicine 75, no. 1 (January 2008): 70–78.
Assan, R., et al. “Dehydroepiandrosterone (DHEA) for Diabetic Patients?” European Journal of Endocrinology 135 (1996): 37–38.
Basualdo, C. G., M.Sc., R.D., et al. “Vitamin A (Retinol) Status of First Nation Adults with Non-Insulin Dependent Diabetes Mellitus.” Journal of the American College of Nutrition 16, no. 1 (1997): 38–45.
Bode, A. M. “Metabolism of Vitamin C in Health and Disease.” Advances in Pharmacology 40 (1997): 334–44.
Boldyrev, A., et al. “Carnosine Protects Against Excitotoxic Cell Death Independently of Effects on Reactive Oxygen Species.” Neuroscience 94, no. 2 (1999): 571–77.
Cameron, N. E., A. M. Jack, and M. A. Cotter. “Effect of Alpha-Lipoic Acid on Vascular Responses and Nociception in Diabetic Rats.” Free Radical Biology Medicine 31, no. 1 (July 1, 2001): 125–35.
Cao, H., I. Hininger-Favier, M. A. Kelly, et al. “Green Tea Polyphenol Extract Regulates the Expression of Genes Involved in Glucose Uptake and Insulin Signaling in Rats Fed a High Fructose Diet.” Journal of Agricultural and Food Chemistry 55, no. 15 (July 25, 2007): 6372–78.
Ceriello, A., M.D., et al. “Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications?” Diabetes Care 14, no. 1 (January 1991): 68–72.
Challem, J. “Antioxidants Might Ease Diabetic Complications.” Medical Tribune, December 12, 1996, 18.
Dela, F. “On the Influence of Physical Training on Glucose Homeostasis.” Acta Physiologica Scandinavica (1996): 5–33.
Gillies, C. L., et al. “Pharmacological and Lifestyle Interventions to Prevent or Delay Type 2 Diabetes in People with Impaired Glucose Tolerance: Systematic Review and Meta-Analysis.” British Medical Journal, doi: 10.1136/bmj.39063.689375.55.
Greenwood-Robinson, M. “Start Your Fat-Burning Engine.” Let’s Live (December 2001).
Heitzer, T., et al. “Beneficial Effects of Alpha-Lipoic Acid and Ascorbic Acid on Endothelium-Dependent, Nitric Oxide-Mediated Vasodilation in Diabetic Patients: Relation to Parameters of Oxidative Stress.” Free Radical Biology Medicine 31, no. 1 (July 1, 2001): 53–61.
Holliday, R., and G. A. McFarland. “A Role for Carnosine in Cellular Maintenance.” Biochemistry (Moscow) 65, no. 7 (July 2000): 843–48.
Houstis, N., E. D. Rosen, and E. S. Lander. “Reactive Oxygen Species Have a Causal Role in Multiple Forms of Insulin Resistance.” Nature 440, no. 7086 (April 2006): 944–48.
Ishihara, K., et al. “Chronic (-)-Hydroxycitrate Administration Spares Carbohydrate Utilization and Promotes Lipid Oxidation During Exercise in Mice.” Journal of Nutrition 130, no. 12 (December 2000): 2990–95.
Jain, S. K., Ph.D., et al. “Effect of Modest Vitamin E Supplementation on Blood Glycated Hemoglobin and Triglyceride Levels and Red Cell Indices in Type I Diabetic Patients.” Journal of the American College of Nutrition 15, no. 5 (1996): 458–61.
_____. “Hyperglycemia Can Cause Membrane Lipid Peroxidation and Osmotic Fragility in Human Red Blood Cells.” Journal of Biological Chemistry 264, no. 35 (December 15, 1989): 21340–45.
Kakkar, R., et al. “Antioxidant Defense System in Diabetic Kidney: A Time Course Study.” Life Sciences 60, no. 9 (1997): 667–79.
Lee, H. A., and D. A. Hughes. “Alpha-Lipoic Acid Modulates NF-Kappab Activity in Human Monocytic Cells by Direct Interaction with DNA.” Experimental Gerontology 37, nos. 2–3 (January 3, 2002): 401–10.
Lincoff, M. A., K. Wolski, and S. J. Nicholls. “Pioglitazone and Risk of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials.” Journal of the American Medical Association 298, no. 10 (2007): 1180–88.
Liu, F., et al. “An Extract of Lagerstroemia speciosa L. Has Insulin-Like Glucose Uptake-Stimulatory and Adipocyte Differentiation-Inhibitory Activities in 3T3-L1 Cells.” Journal of Nutrition 131, no. 9 (September 2001): 2242–47.
Lutsey, P. L., L. M. Steffen, and J. Stevens. “Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study.” Circulation 117, no. 6 (February 2008): 754–61.
Mahendran, P., A. J. Vanisree, and C. S. Shyamala Devi. “The Antiulcer Activity of Garcinia Cambogia Extract Against Indomethacin-Induced Gastric Ulcer in Rats.” Phytotherapy Research 16, no. 1 (February 2002): 80–83.
Matsukura, T., and H. Tanaka. “Applicability of Zinc Complex of L-Carnosine for Medical Use.” Biochemistry (Moscow) 65, no. 7 (July 2000): 817–23.
McFarland, G. A., and R. Holliday. “Further Evidence for the Rejuvenating Effects of the Dipeptide L-Carnosine on Cultured Human Diploid Fibroblasts.” Experimental Gerontology 34, no. 1 (January 1999): 35–45.
Melhem, M. F., P. A Craven, J. Liachenko, and F. R. DeRubertis. “Alpha-Lipoic Acid Attenuates Hyperglycemia and Prevents Glomerular Mesangial Matrix Expansion in Diabetes.” Journal of the American Society of Nephrology 13, no. 1 (January 2002): 108–16.
Nissen, S. E., and K. Wolski. “Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.” New England Journal of Medicine 356, no. 24 (June 14, 2007): 2457–71.
Ohia, S. E., et al. “Effect of Hydroxycitric Acid on Serotonin Release from Isolated Rat Brain Cortex.” Research Communications in Molecular Pathology and Pharmacology 109, nos. 3–4 (March–April 2001): 210–16.
Osterode, W., et al. “Nutritional Antioxidants, Red Cell Membrane Fluidity and Blood Viscosity in Type I (Insulin Dependent) Diabetes Mellitus.” Diabetic Medicine 13 (1996): 1044–50.
Persson, H. L., A. I. Svensson, and U. T. Brunk. “Alpha-Lipoic Acid and Alpha-Lipoamide Prevent Oxidant-Induced Lysosomal Rupture and Apoptosis.” Redox Report: Communications in Free Radical Research 6, no. 5 (2001): 327–34.
Pick, M. E., M.Sc., R.D., et al. “Oat Bran Concentrate Bread Products Improve Long-Term Control of Diabetes: A Pilot Study.” Journal of the American Dietetic Association 96, no. 12 (December 1996): 1254–61.
Preuss, H. G., S. Montamarry, and B. Echard, et al. “Long-Term Effects of Chromium, Grape Seed Extract, and Zinc on Various Metabolic Parameters of Rats.” Molecular and Cellular Biochemistry 223, nos. 1–2 (July 2001): 95–102.
Schlosser, E. Fast Food Nation: The Dark Side of the All-American Meal. New York: Harper-Collins, Inc., 2002.
Seo, K. I., M. S. Choi, U. J. Jung, et al. “Effect of Curcumin Supplementation on Blood Glucose, Plasma Insulin, and Glucose Homeostasis Related Enzyme Activities in Diabetic Db/Db Mice.” Molecular Nutrition and Food Research, 52, no. 9 (April 2008): 995–1004.
Serisier, S., V. Leray, and W. Poudroux, et al. “Effects of Green Tea on Insulin Sensitivity, Lipid Profile and Expression of PPARalpha and PPARgamma and Their Target Genes in Obese Dogs.” British Journal of Nutrition 99, no. 6 (June 2008): 1208–16.
Shi, H., D. Dirienzo, and M. B. Zemel. “Effects of Dietary Calcium on Adipocyte Lipid Metabolism and Body Weight Regulation in Energy-Restricted Ap2-Agouti Transgenic Mice.” The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 15, no. 2 (February 2001): 291–93.
Sigal, R. J., et al. “Physical Activity/Exercise and Type 2 Diabetes: A Consensus Statement from the American Diabetes Association.” Diabetes Care (2006): 1433–38.
Solomon, D. H., and W. C. Winkelmayer. “Cardiovascular Risk and the Thiazolidinediones: Déjà Vu All Over Again?” Journal of the American Medical Association 298, no. 10 (2007): 1216–18.
Suzuki, Y., et al. “Antiobesity Activity of Extracts from Lagerstroemia speciosa L. Leaves on Female KK-Ay Mice.” Journal of Nutritional Science and Vitaminology (Tokyo) 45, no. 6 (1999): 791–95.
Trehan, S., M.D., et al. “Magnesium Disorders: What to Do When Homeostasis Goes Awry.” Consultant (November 1996): 2485–97.
Tsuda, T., “Regulation of Adipocyte Function by Anthocyanins; Possibility of Preve
nting the Metabolic Syndrome.” Journal of Agricultural and Food Chemistry 56, no. 3 (February 2008): 642–46.
Tuominen, J. A., et al. “Exercise Increases Insulin Clearance in Healthy Men and Insulin-Dependent Diabetes Mellitus Patients.” Clinical Physiology 17 (1997): 19–30.
Vaccaro, O., et al. “Moderate Hyperhomo-cysteinaemia and Retinopathy in Insulin-Dependent Diabetes.” The Lancet 349 (April 12, 1997): 1102–103.
Zhang, W. J., and B. Frei. “Alpha-Lipoic Acid Inhibits TNF-Alpha-Induced NF-Kappab Activation and Adhesion Molecule Expression in Human Aortic Endothelial Cells.” The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 15, no. 13 (November 2001): 2423–32.
Chapter 17
Drugs for Eye Diseases and Their Natural Alternatives
Albert, D., M.D., et al. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia, PA: W. B. Saunders, 1994.
Baudoin, C., et al. “Expression of Inflammatory Membrane Markers by Conjunctival Cells in Chronically Treated Patients with Glaucoma.” Ophthalmology 101 (1994): 454–60.
Boulton, M., et al. “Lipofuscin Is a Photoinducible Free Radical Generator.” Journal of Photochemistry and Photobiology, B-Biology 19, no. 3 (August 1993): 201–4.
Caprioli J., M. Sears, L. Bausher, et al. Forskolin Lowers Intraocular Pressure by Reducing Aqueous Inflow.” Investigative Ophthalmology & Visual Science 25 (1984): 268–277.
Caprioli, J., and M. Sears. “Forskolin Lowers Intraocular Pressure in Rabbits, Monkeys, and Man.” The Lancet 1 (1983): 958-960.
Connor, W. E., et al. “Essential Fatty Acids: The Importance of N-3 Fatty Acids in the Retina and Brain.” Nutrition Reviews 50 (1992): 21–29.
Czernin, J., et al. “Effect of Short-Term Cardiovascular Conditioning and Low-Fat Diet on Myocardial Blood Flow and Flow Reserve.” Circulation 92, no. 2 (July 15, 1995): 192–204.
Ferris, F. L. “Senile Macular Degeneration: Review of Epidemiologic Features.” American Journal of Epidemiology 118 (1983): 132–50.
Prescription Alternatives Page 63